Skip to main content
Top
Published in: BMC Health Services Research 1/2019

Open Access 01-12-2019 | Shock | Research article

Economic and non-economic determinants of Iranian pharmaceutical companies’ financial performance: an empirical study

Authors: Mohammadreza Masoumi, Farbod Ebadi Fard Azar, Aziz RezaPour, Mohsen Mehrara

Published in: BMC Health Services Research | Issue 1/2019

Login to get access

Abstract

Background

The pharmaceutical industry in Iran is influenced by various parameters such as internal factors caused by the financial information of each economic unit and external factors including major economic and non-economic variables.

Methods

This study is aiming to examine the effect of such variables on the stock return of 34 pharmaceutical companies in the Tehran Securities Exchange market using quarterly data from 1995 to 2016. In this research, an autoregressive model was utilized to examine the way that variables affect the stock market index. In such patterns, there is no need for explicit short-term structural relationships and structural knowledge is extracted from causal relationships. Finally, to analyze the results, impulse-response functions, forecast error variance, and historical decomposition were collected.

Results

Results of this research show that positive shock to the variables, namely the currency rate, collection period of quests, and healthcare costs lead to a decrease in the return of pharmaceutical companies. On the other hand, a positive shock to the variables such as GDP, and money volume, leads to an increase in the stock return of pharmaceutical companies.

Conclusion

Different factors contribute to the stock return of pharmaceutical companies. Among the variables examined in this study, market currency rate, money volume, pharmaceutical sector inflation, bank interest rate, GDP in the healthcare sector, healthcare costs, and collection period of quests have the most effect on describing changes within the stock return of pharmaceutical companies.
Literature
3.
go back to reference Cheraghali AM. Trends in Iran pharmaceutical market. Iranina J Pharm Res. 2017;16(1):1–7.CrossRef Cheraghali AM. Trends in Iran pharmaceutical market. Iranina J Pharm Res. 2017;16(1):1–7.CrossRef
4.
go back to reference Karampli E, Souliotis K, Polyzos N, Kyriopulos J, Chatzaki E. Pharmaceutical innovation: impact on expenditure and outcomes and subsequent challenges for pharmaceutical policy, with a special reference to Greece. Hippokratia. 2014;18(2):100–6.PubMedPubMedCentral Karampli E, Souliotis K, Polyzos N, Kyriopulos J, Chatzaki E. Pharmaceutical innovation: impact on expenditure and outcomes and subsequent challenges for pharmaceutical policy, with a special reference to Greece. Hippokratia. 2014;18(2):100–6.PubMedPubMedCentral
6.
go back to reference Allahawiah S, Al Amro S. Factors affecting stock market prices in Amman Stock Exchange: A Survey Study. Eur J Bus Manag. 2012;4(8):236–45. Allahawiah S, Al Amro S. Factors affecting stock market prices in Amman Stock Exchange: A Survey Study. Eur J Bus Manag. 2012;4(8):236–45.
7.
go back to reference Sharpe W. Capital asset prices: a theory of market equilibrium under conditions of risk. J Finance. 1964;19:425–42. Sharpe W. Capital asset prices: a theory of market equilibrium under conditions of risk. J Finance. 1964;19:425–42.
8.
go back to reference Lintner J. Security prices, risk, and maximal gains from diversification. J Finance. 1965;20:587–615. Lintner J. Security prices, risk, and maximal gains from diversification. J Finance. 1965;20:587–615.
9.
go back to reference Heidari H, Refah Kahriz A, Mohammadzadeh Y. Stock market behavior of pharmaceutical industry in Iran and macroeconomic factors. Econ Change Restruct. 2019;52:255–77.CrossRef Heidari H, Refah Kahriz A, Mohammadzadeh Y. Stock market behavior of pharmaceutical industry in Iran and macroeconomic factors. Econ Change Restruct. 2019;52:255–77.CrossRef
10.
go back to reference Peiro A. Stock prices and macroeconomic factors: some European evidence. Int Rev Econ Finance. 2016;41(1):287–94.CrossRef Peiro A. Stock prices and macroeconomic factors: some European evidence. Int Rev Econ Finance. 2016;41(1):287–94.CrossRef
11.
go back to reference Pardhan R, Arvin M, Ghoshary A. The dynamics of economic growth, oil prices, stock market depth, and other macroeconomic variables: evidence from the G-20 countries. Int Rev Financ Anal. 2015;39:84–95.CrossRef Pardhan R, Arvin M, Ghoshary A. The dynamics of economic growth, oil prices, stock market depth, and other macroeconomic variables: evidence from the G-20 countries. Int Rev Financ Anal. 2015;39:84–95.CrossRef
12.
go back to reference Chen M. Macro and non-macro explanatory factors of Chinese hotel stock returns. Int J Hosp Manag. 2007;29(4):991–1004.CrossRef Chen M. Macro and non-macro explanatory factors of Chinese hotel stock returns. Int J Hosp Manag. 2007;29(4):991–1004.CrossRef
13.
go back to reference Agnello L, Ricardo M. Fiscal policy and asset prices. Bull Econ Res. 2013;65(2):154–77.CrossRef Agnello L, Ricardo M. Fiscal policy and asset prices. Bull Econ Res. 2013;65(2):154–77.CrossRef
14.
go back to reference Laopodis NT. Dynamic linkages between monetary policy and the Stock market. Rev Quant Finan Acc. 2010;35(4):271–93.CrossRef Laopodis NT. Dynamic linkages between monetary policy and the Stock market. Rev Quant Finan Acc. 2010;35(4):271–93.CrossRef
15.
go back to reference Emadzadeh M, Zaree F, Torosian A. Micro and macro indicators affecting stock returns. Econ J. 2011;3:31–44. Emadzadeh M, Zaree F, Torosian A. Micro and macro indicators affecting stock returns. Econ J. 2011;3:31–44.
16.
go back to reference Wang Z. Stock returns and the short-run predictability of health expenditure: some empirical evidence. Int J Forecast. 2009;25:587–601.CrossRef Wang Z. Stock returns and the short-run predictability of health expenditure: some empirical evidence. Int J Forecast. 2009;25:587–601.CrossRef
17.
go back to reference Assefa T, Esqueda O, Mollick A. Stock returns and interest rates around the world: a panel data approach. J Econ Bus. 2017;89:20–35.CrossRef Assefa T, Esqueda O, Mollick A. Stock returns and interest rates around the world: a panel data approach. J Econ Bus. 2017;89:20–35.CrossRef
18.
go back to reference Gordon JM. Dividend, earning and stock price. Rev Econ Stat. 1959;41(2):99–105.CrossRef Gordon JM. Dividend, earning and stock price. Rev Econ Stat. 1959;41(2):99–105.CrossRef
19.
go back to reference Dierks RML, Bruyère O, Reginster JY, Richy FF. Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry. Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):571–8.CrossRef Dierks RML, Bruyère O, Reginster JY, Richy FF. Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry. Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):571–8.CrossRef
20.
go back to reference Gonzalez CI, Gimeno R. Financial analysts impact on stock volatility: a study on the pharmaceutical sector. fundacoَn de estudios de economيa aplicada (fedea). FEDEA Working Paper No; 2008. p. 1–28. Available at SSRN: https://ssrn.com/abstr act=11329 38 Gonzalez CI, Gimeno R. Financial analysts impact on stock volatility: a study on the pharmaceutical sector. fundacoَn de estudios de economيa aplicada (fedea). FEDEA Working Paper No; 2008. p. 1–28. Available at SSRN: https://​ssrn.​com/​abstr act=11329 38
21.
go back to reference Chizari M, Zare Mehrjardi R, Mirmohammadi M, Kalantar MF. The impact of intellectual capitals of pharmaceutical companies listed in Tehran Stock exchange on their market performance. Procedia Econ Finance. 2016;36:291–300.CrossRef Chizari M, Zare Mehrjardi R, Mirmohammadi M, Kalantar MF. The impact of intellectual capitals of pharmaceutical companies listed in Tehran Stock exchange on their market performance. Procedia Econ Finance. 2016;36:291–300.CrossRef
22.
go back to reference Mohammadzadeh M, Rahimi F, Rahimi F, Aarabi SM, Salamzadeh J. The effect of capital structure on the profitability of pharmaceutical companies the case of Iran. Iran J Pharm Res. 2013;12(3):573.PubMedPubMedCentral Mohammadzadeh M, Rahimi F, Rahimi F, Aarabi SM, Salamzadeh J. The effect of capital structure on the profitability of pharmaceutical companies the case of Iran. Iran J Pharm Res. 2013;12(3):573.PubMedPubMedCentral
23.
go back to reference Zartab S, Fatemi SF, Radmanesh R. Fundamentals and stock return in pharmaceutical companies: a panel data model of Iranian industry. Iran J Pharm Sci. 2013;9(1):55–60. Zartab S, Fatemi SF, Radmanesh R. Fundamentals and stock return in pharmaceutical companies: a panel data model of Iranian industry. Iran J Pharm Sci. 2013;9(1):55–60.
24.
go back to reference Rasekh HR, Mehralian G, Vatankhah-Mohammadabadi AA. Situation analysis of R&D activities: an empirical study in Iranian pharmaceutical companies. Iran J Pharm Res. 2012;11(4):1013.PubMedPubMedCentral Rasekh HR, Mehralian G, Vatankhah-Mohammadabadi AA. Situation analysis of R&D activities: an empirical study in Iranian pharmaceutical companies. Iran J Pharm Res. 2012;11(4):1013.PubMedPubMedCentral
25.
go back to reference Markowitz H. Portfolio selection. J Financ. 1952;7(1):77–91. Markowitz H. Portfolio selection. J Financ. 1952;7(1):77–91.
26.
go back to reference Stock J, Watson M. Forecasting output and inflation: the role of asset prices. J Econ Lit. 2003;41:788–829.CrossRef Stock J, Watson M. Forecasting output and inflation: the role of asset prices. J Econ Lit. 2003;41:788–829.CrossRef
27.
go back to reference Sims CA. The role of approximate prior restrictions in distributed lag estimation. J Am Stat Assoc. 1972;67(337):169–75.CrossRef Sims CA. The role of approximate prior restrictions in distributed lag estimation. J Am Stat Assoc. 1972;67(337):169–75.CrossRef
28.
29.
go back to reference Sims CA. Comparison of interwar and postwar business cycles: monetarism reconsidered. Am Econ Rev. 1980b;70(2):250–7. Sims CA. Comparison of interwar and postwar business cycles: monetarism reconsidered. Am Econ Rev. 1980b;70(2):250–7.
30.
go back to reference Bjørnland HC, Leitemo K. Identifying the interdependence between US monetary policy and the stock market. J Monetary Econ. 2009;56(2):275–82.CrossRef Bjørnland HC, Leitemo K. Identifying the interdependence between US monetary policy and the stock market. J Monetary Econ. 2009;56(2):275–82.CrossRef
31.
go back to reference Bernanke B, Mihov I. Measuring monetary policy. Q J Econ. 1998;108(3):869–902.CrossRef Bernanke B, Mihov I. Measuring monetary policy. Q J Econ. 1998;108(3):869–902.CrossRef
32.
go back to reference Bernanke B, Blinder A. The Federal Funds Rate and the Channels of Monetary Transmission. American Econ Rev. 1992;82(4):901–21. Bernanke B, Blinder A. The Federal Funds Rate and the Channels of Monetary Transmission. American Econ Rev. 1992;82(4):901–21.
33.
go back to reference Jalali Naini AR, Naderian MA. Financial Vulnerability and Stabilization Policy in Commodity Exporting Emerging Economies. MPRA Paper 84481. Germany: University Library of Munich; 2017. Jalali Naini AR, Naderian MA. Financial Vulnerability and Stabilization Policy in Commodity Exporting Emerging Economies. MPRA Paper 84481. Germany: University Library of Munich; 2017.
34.
go back to reference Enders W. Applied econometric time series: Wiley; University of Alabama; 2008. Enders W. Applied econometric time series: Wiley; University of Alabama; 2008.
35.
go back to reference Parkyn O, Vehbi T. The effects of fiscal policy in New Zealand: Evidence from a VAR model with debt constraints. Economic Record. 2014;90(290):345-64.CrossRef Parkyn O, Vehbi T. The effects of fiscal policy in New Zealand: Evidence from a VAR model with debt constraints. Economic Record. 2014;90(290):345-64.CrossRef
36.
go back to reference Chue TK, Cook D. Emerging market exchange rate exposure. J Bank Financ. 2008;32(7):1349–62.CrossRef Chue TK, Cook D. Emerging market exchange rate exposure. J Bank Financ. 2008;32(7):1349–62.CrossRef
37.
go back to reference Alboseylam M, Karimi H. The impact of monetary policy on Tehran stock exchange index with emphasis on the financial crisis in 2007. Q J Securities Exch. 2012;4(15):89–105. Alboseylam M, Karimi H. The impact of monetary policy on Tehran stock exchange index with emphasis on the financial crisis in 2007. Q J Securities Exch. 2012;4(15):89–105.
38.
go back to reference Karimzadeh M, Soltani A. Estimate long term relationship of financial intermediation stock price with macroeconomic variable: ARDL approach. Q Financial Accounting. 2009;1(4):547–63. Karimzadeh M, Soltani A. Estimate long term relationship of financial intermediation stock price with macroeconomic variable: ARDL approach. Q Financial Accounting. 2009;1(4):547–63.
39.
go back to reference Ghalmagh K. The effect of monetary policy, central bank activities Tehran Stock Exchange: Master Thesis. Tehran: Shahid Beheshti University; 2004. Ghalmagh K. The effect of monetary policy, central bank activities Tehran Stock Exchange: Master Thesis. Tehran: Shahid Beheshti University; 2004.
40.
go back to reference Thorbecke W. On stock market returns and monetary policy. J Financ. 1997;52(2):635–54.CrossRef Thorbecke W. On stock market returns and monetary policy. J Financ. 1997;52(2):635–54.CrossRef
41.
go back to reference Patelis AD. Stock return predictability and the role of monetary policy. J Financ. 1997;52(5):1951–72.CrossRef Patelis AD. Stock return predictability and the role of monetary policy. J Financ. 1997;52(5):1951–72.CrossRef
42.
go back to reference Fama EF, Schwert GW. Asset returns and inflation. J Financ Econ. 1977;5:115–46.CrossRef Fama EF, Schwert GW. Asset returns and inflation. J Financ Econ. 1977;5:115–46.CrossRef
43.
go back to reference Flannery MJ, James CM. The effect of interest rate changes on the common Stock returns of financial institutions. J Financ. 1984;39(4):1141–53.CrossRef Flannery MJ, James CM. The effect of interest rate changes on the common Stock returns of financial institutions. J Financ. 1984;39(4):1141–53.CrossRef
44.
go back to reference Bernanke B, Gertler M, Gilchrist S. The financial accelerator in a quantitative business cycle framework. NBER Working Paper. 1998;6455:9-16. Bernanke B, Gertler M, Gilchrist S. The financial accelerator in a quantitative business cycle framework. NBER Working Paper. 1998;6455:9-16.
Metadata
Title
Economic and non-economic determinants of Iranian pharmaceutical companies’ financial performance: an empirical study
Authors
Mohammadreza Masoumi
Farbod Ebadi Fard Azar
Aziz RezaPour
Mohsen Mehrara
Publication date
01-12-2019
Publisher
BioMed Central
Keywords
Shock
Shock
Published in
BMC Health Services Research / Issue 1/2019
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-019-4735-4

Other articles of this Issue 1/2019

BMC Health Services Research 1/2019 Go to the issue